165 related articles for article (PubMed ID: 6185132)
21. [Clinical studies on serum beta2-microglobulin in multiple myeloma and other related diseases (author's transl)].
Nishioka F; Yachi A; Wada T
Rinsho Ketsueki; 1978 Feb; 19(2):100-6. PubMed ID: 77342
[No Abstract] [Full Text] [Related]
22. Clinical significance of correction of serum beta 2-microglobulin levels for serum creatinine in multiple myeloma.
Scudla V; Vavrdová V; Budíková M; Indrák K
Acta Univ Palacki Olomuc Fac Med; 1991; 131():257-64. PubMed ID: 1840347
[TBL] [Abstract][Full Text] [Related]
23. Bone marrow histology and serum beta 2 microglobulin in multiple myeloma--a new prognostic strategy.
Bartl R; Frisch B; Diem H; Mündel M; Fateh-Moghadam A
Eur J Haematol Suppl; 1989; 51():88-98. PubMed ID: 2697597
[TBL] [Abstract][Full Text] [Related]
24. [Analysis of serum beta 2-microglobulin in multiple myeloma, non-Hodgkin's malignant lymphoma and chronic lymphoid leukemia].
Balikó Z; Tornóczky J; Pasztarak E; Tóth A; Muth L
Orv Hetil; 1983 Jan; 124(3):131-4. PubMed ID: 6188088
[No Abstract] [Full Text] [Related]
25. [Role of the assay of serum beta 2 microglobulin in the clinical evaluation of myeloma].
Bataille R; Grenier J
Presse Med; 1986 Oct; 15(34):1723-5. PubMed ID: 2947132
[TBL] [Abstract][Full Text] [Related]
26. Serum beta 2-microglobulin in myelomatosis.
Child JA; Norfolk DR; Cooper EH
Br J Haematol; 1986 Jun; 63(2):406-7. PubMed ID: 3521716
[No Abstract] [Full Text] [Related]
27. [Prognostic significance of beta-2-microglobulin in multiple myeloma].
Podol'tseva EI; Morozova EV; Almazov VA
Vopr Onkol; 1996; 42(4):32-5. PubMed ID: 8928455
[TBL] [Abstract][Full Text] [Related]
28. Stratification of multiple myeloma according to serum beta 2-microglobulin and serum albumin levels.
Scudla V; Budíková M; Fischerová E; Zadrazil J; Indrák K
Acta Univ Palacki Olomuc Fac Med; 1991; 130():201-12. PubMed ID: 1838869
[TBL] [Abstract][Full Text] [Related]
29. Serum beta-2-microglobulin estimation as an indicator of the glomerular filtration rate.
Jialal I; Nathoo BC; Bejai S; Joubert SM
S Afr Med J; 1982 Jun; 61(25):953-4. PubMed ID: 6178173
[TBL] [Abstract][Full Text] [Related]
30. Multiple myeloma: beta-2-microglobulin is not a useful follow-up parameter.
Boccadoro M; Omedè P; Frieri R; Battaglio S; Gallone G; Massaia M; Redoglia V; Pileri A
Acta Haematol; 1989; 82(3):122-5. PubMed ID: 2510433
[TBL] [Abstract][Full Text] [Related]
31. [Clinical usefulness of serum beta2-microglobulin determination in patients with multiple myeloma].
Kraj M; Maj S; Pogłód R; Rostkowska J
Acta Haematol Pol; 1989; 20(2):140-51. PubMed ID: 2700533
[TBL] [Abstract][Full Text] [Related]
32. A plea to overcome the concept of "staging" and related inadequacy in multiple myeloma.
Gobbi PG; Bertoloni D; Grignani G; Pieresca C; Rossi A; Rutigliano L; Merlini G; Riccardi A; Ascari E
Eur J Haematol; 1991 Mar; 46(3):177-81. PubMed ID: 2009950
[TBL] [Abstract][Full Text] [Related]
33. Staging multiple myeloma patients with active disease using serum levels of beta2m-free HLA class I heavy chain together with IgM or platelet count.
Perosa F; Minoia C; Favoino E; Prete M; Dammacco F
Blood Cells Mol Dis; 2009; 42(1):71-6. PubMed ID: 18996035
[TBL] [Abstract][Full Text] [Related]
34. Beta 2-microglobulin in monoclonal gammopathies.
Vercelli D; Cozzolino F; Becucci A; Di Guglielmo R
Nouv Rev Fr Hematol (1978); 1982; 24(2):85-8. PubMed ID: 6180380
[No Abstract] [Full Text] [Related]
35. Serum beta 2 microglobulin and its prognostic value in lymphomas.
Amlot PL; Adinolfi M
Eur J Cancer (1965); 1979 May; 15(5):791-6. PubMed ID: 92408
[No Abstract] [Full Text] [Related]
36. Beta2-microglobulin levels of serum and ascites in malignant diseases.
Kin K; Sakurabayashi I; Kawai T
Gan; 1977 Aug; 68(4):427-34. PubMed ID: 80342
[TBL] [Abstract][Full Text] [Related]
37. [Prognostic analysis and assessment on the clinical staging systems of multiple myeloma--a report of 206 cases].
Tao ZF; Fu WJ; Chen YB; Yuan ZG; Wang DX; Hou J
Ai Zheng; 2006 Apr; 25(4):461-4. PubMed ID: 16613681
[TBL] [Abstract][Full Text] [Related]
38. Beta-2-microglobulin: a valuable parameter of stage, prognosis and response to treatment in myelomatosis.
Bjerrum OW; Plesner T
Scand J Haematol; 1985 Jul; 35(1):22-5. PubMed ID: 3901240
[No Abstract] [Full Text] [Related]
39. Beta 2-microglobulin: a potentially useful marker for hematologic malignancies.
Garewal H; Durie BG
Ariz Med; 1981 Dec; 38(12):912-3. PubMed ID: 6174109
[No Abstract] [Full Text] [Related]
40. A new staging system for multiple myeloma patients based on the Southwest Oncology Group (SWOG) experience.
Jacobson JL; Hussein MA; Barlogie B; Durie BG; Crowley JJ;
Br J Haematol; 2003 Aug; 122(3):441-50. PubMed ID: 12877671
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
